From Consortium to Classic
How Open Collaboration Shaped a Landmark Review on Natural Products
The Paper
The Story Behind the Paper
It is a particular honor to reflect on our paper, “Natural products in drug discovery: advances and opportunities,” published in Nature Reviews Drug Discovery, within the context of the revived Citation Classics series. When we initiated this work, our ambition was to provide a comprehensive, forward-looking perspective on the evolving role of natural products in modern pharmaceutical research. We did not anticipate the remarkable visibility and sustained impact the article would achieve.
In retrospect, one of the key reasons for its success lies in its deeply interdisciplinary character. The article did not merely review technological advances in analytical chemistry, genome mining, or synthetic biology; it integrated insights spanning pharmacology, medicinal chemistry, molecular biology, biotechnology, and translational medicine. Crucially, this integration was made possible by the collaborative network fostered by the International Natural Product Sciences Taskforce (INPST), which I founded and have the privilege of leading. Through INPST’s networking activities, we brought together leading academic and industrial representatives in the field of natural product sciences. The manuscript thus became not only a scientific synthesis but also a testament to the power of open innovation and international collaboration.
One aspect that genuinely surprised me during the process was the intensity and duration of the revision journey. Although I was aware that publishing in a high-impact journal requires rigorous scrutiny, I did not fully anticipate the number of revision rounds and the substantial writing effort required before the manuscript reached its final accepted form. Each round demanded careful harmonization of viewpoints, updating of references, and sharpening of conceptual framing. In the end, the manuscript benefited enormously from this process, but it was certainly more demanding than initially expected.
Looking back, there is one strategic element I might approach differently. At the outset, we divided the manuscript into several sections, each drafted independently by a team of co-authors contributing their domain-specific expertise. While this approach efficiently mobilized the breadth of knowledge within the consortium, integrating these sections into a coherent, unified narrative proved more challenging than anticipated. Ultimately, the later revision rounds were written largely by me to ensure stylistic and conceptual consistency. In hindsight, it might have been more efficient if I had drafted the entire first version myself, guided by a structured list of bullet points and recommendations from the diverse co-authors. Such a strategy could have preserved the multidisciplinary richness while facilitating smoother integration from the beginning.
Reflecting on the broader impact of this publication, I feel deep gratitude. No scientific achievement stands alone. I would like to express my heartfelt thanks to my key mentors: Professors Alex Odermatt, Verena M. Dirsch, Jarosław Olav Horbańczuk, Maria Kletecka-Pulker, Harald Willschke, Thomas Brunner, and Agnieszka Wierzbicka for their guidance and inspiration. I am equally thankful to my peers and collaborators: Artur Jóźwik, Maima Matin, Nikolay T. Tzvetkov, Olena Litvinova, Michel-Edwar Mickael, Andy Wai Kan Yeung, and many other co-workers and research partners, who have supported and shaped my scientific development.
I am also profoundly grateful to the organizations that supported my scientific work, including Narodowe Centrum Nauki, the Roche Research Foundation, the Austrian Science Fund (FWF), the 7th Framework Programme (FP7) of the European Union, and the Hochschuljubiläumsfonds der Stadt Wien. Finally, I wish to acknowledge the institutions that hosted and enabled my research, especially the Ludwig Boltzmann Institute Digital Health and Patient Safety, the Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Danube Private University, the University of Vienna, and the University of Bern.
If this article has become a “citation classic,” it is not solely because of the topic it addressed, but because it emerged from a vibrant, collaborative scientific community committed to advancing natural product research for the benefit of patients and society.